You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Motor neurone disease

Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease

  • Technology appraisal guidance
  • Reference number: TA20
  • Published:  23 January 2001
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Other information
  2. Background information

History

A list of downloadable documents created during development.

Other information

  • TA20 Motor neurone disease - riluzole: guidance (html) information

Background information

  • Motor neurone disease - riluzole: Static List Review Decision - April 2014 information

  • Appendix A -Static List Review paper

  • Appendix A -Static List Review paper (PDF 185 KB)

    Published:
    01 April 2014
  • Riluzole for Motor Neurone Disease - HTA report part 1

  • Riluzole for Motor Neurone Disease - HTA report part 1 (PDF 833 KB)

    Published:
    22 January 2001
  • Riluzole for Motor Neurone Disease - HTA report part 2

  • Riluzole for Motor Neurone Disease - HTA report part 2 (PDF 31 KB)

    Published:
    22 January 2001
  • Riluzole - Appeal against guidance dated December 2000 information

  • Review of TA20 Riluzole for the treatment of motor neurone disease  information

  • Review proposal

  • Review proposal (MSWord 37 KB)

    Published:
    06 February 2006
  • Review decision information

Back to top